CA Stock MarketDetailed Quotes
QNTM Quantum BioPharma Ltd
- 7.300
- +0.100+1.39%
15min DelayMarket Closed Nov 15 14:39 ET
13.56MMarket Cap-410P/E (TTM)
7.300High7.250Low603Volume7.250Open7.200Pre Close4.39KTurnover12.22052wk High0.04%Turnover Ratio1.86MShares4.85052wk Low-17.782EPS TTM11.24MFloat Cap12.220Historical HighLossP/E (Static)1.54MShs Float4.850Historical Low-39.637EPS LYR0.69%Amplitude--Dividend TTM0.88P/B1Lot Size--Div YieldTTM
About Quantum BioPharma Ltd Company
Quantum BioPharma Ltd formerly FSD Pharma Inc is a biopharmaceutical company developing three clinical candidates with the potential to address neuropsychiatric, neurodegenerative, and inflammatory disorders. Along with its subsidiaries, the group is focused on pharmaceutical research and development of its compound, FSD201, an ultra-micronized PEA, for the treatment of inflammatory diseases; Lucid-Psych is used in the treatment of mental health disorders and Lucid-MS is used in the treatment of neurodegenerative disorders. The company operates in two segments: Biopharmaceutical and Strategic Investments.
Company Profile
SymbolQNTM
Company NameQuantum BioPharma Ltd
Founded1994
MarketCNQ
Employees8
Fiscal Year Ends12-31
Address199 Bay Street Suite 4000
CityToronto
CountryCAN
Zip CodeM5L 1A9
Phone+1 416 854-8884
Websitehttps://www.fsdpharma.com
Company Executives
- Name
- Position
- Salary
- Zeeshan Saeed
- Chief Executive Officer, Co-Executive Chairman of the Board and President
- 599.87K
- Dr. Lakshmi P. Kotra
- Chief Executive Officer, Lucid Psycheceuticals Inc. and FSD Australia; Director
- 521.97K
- Nathan Coyle
- Chief Financial Officer
- 178.21K
- Donal Carroll
- Chief Operating Officer
- 602.87K
- Anthony Durkacz
- Executive Co-Chairman of the Board
- 599.87K
- Sanjiv Chopra
- Independent Director
- --
- Dr. Eric Hoskins
- Independent Director
- --
- Michael Zapolin
- Independent Director
- 126.00K
- Adnan Bashir
- Independent Director
- 139.37K
Heat List
CA
Overall
Symbol
Latest Price
% Chg
No Data